负载circPRKD3的外泌体通过抑制STAT3信号同时抑制肿瘤生长并重塑胶质母细胞瘤微环境
本研究筛选并鉴定胶质瘤干细胞来源外泌体中的circPRKD3,发现其低表达预示胶质母细胞瘤患者预后更差;GDE-circPRKD3以m6A依赖方式结合HNRNPC,加速IL6ST mRNA降解并抑制STAT3,重编程肿瘤相关巨噬细胞促进CXCL10分泌,招募CD8+肿瘤浸润淋巴细胞,脑靶向脂质纳米颗粒递送circPRKD3联合免疫检查点阻断取得显著联合获益。
要点
- GDE-circPRKD3低表达预示胶质母细胞瘤患者预后更差。
- GDE-circPRKD3过表达削弱胶质瘤生物学能力并延长异种移植小鼠生存。
- GDE-circPRKD3经STAT3信号重塑免疫抑制微环境并招募CD8+ T细胞。
核心结论
- 本研究揭示GDE-circPRKD3依赖STAT3信号重塑免疫抑制肿瘤微环境的新机制,并提供一种潜在的胶质母细胞瘤RNA免疫治疗策略。
研究设计与样本
- 通过高通量测序筛选、RT-PCR、Sanger测序和RNase R实验验证GDE-circPRKD3,并开展体外与体内实验研究其功能,用RNA-seq、RNA免疫沉淀、多色流式细胞术和western blotting探究其对STAT3信号介导微环境重塑的调控,另采用脑靶向脂质纳米颗粒递送circPRKD3联合免疫检查点阻断治疗。
主要发现
- GDE-circPRKD3低表达预示胶质母细胞瘤患者预后更差。
- GDE-circPRKD3过表达显著削弱胶质瘤的生物学能力并延长异种移植小鼠生存。
- GDE-circPRKD3以m6A依赖方式结合HNRNPC,加速IL6ST mRNA降解并抑制下游靶点STAT3。
- GDE-circPRKD3通过重编程肿瘤相关巨噬细胞促进CXCL10分泌,进而招募CD8+肿瘤浸润淋巴细胞对抗胶质母细胞瘤。
- 脑靶向脂质纳米颗粒递送circPRKD3联合免疫检查点阻断治疗取得显著联合获益。
临床怎么用
- 作者认为GDE-circPRKD3依赖STAT3信号重塑免疫抑制肿瘤微环境,并提供一种潜在的胶质母细胞瘤RNA免疫治疗策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma stem cells and their exosomes (exos) are involved in shaping the immune microenvironment, which is important for tumor invasion and recurrence. However, studies involving GSC-derived exosomal circular RNAs (GDE-circRNAs) in regulating tumor microenvironment (TME) remain unknown. Here, we comprehensively evaluated the significance of a novel immune-related GDE-circRNA in the glioma microenvironment. METHODS: GDE-circPRKD3 was screened out through high-throughput sequencing and verified by RT-PCR, sanger sequencing, and RNase R assays. A series of in vitro and in vivo experiments were performed to investigate the function of GDE-circPRKD3. RNA-seq, RNA immunoprecipitation, multicolor flow cytometry, and western blotting were used to explore the regulation of GDE-circPRKD3 on STAT3 signaling-mediated TME remodeling. RESULTS: We have characterized a circRNA PRKD3 in GSC exosomes, and lower circPRKD3 expression predicts a worse prognosis for glioblastoma patients. Overexpression of GDE-circPRKD3 significantly impairs the biological competence of glioma and prolongs the survival of xenograft mice. GDE-circPRKD3 binds to HNRNPC in an m6A-dependent manner, accelerates mRNA decay of IL6ST, and inhibits downstream target STAT3. Notably, GDE-circPRKD3 promotes CXCL10 secretion by reprogramming tumor-associated macrophages, which in turn recruits CD8+ tumor-infiltrating lymphocytes against GBM. Moreover, brain-targeted lipid nanoparticle delivery of circPRKD3 combined with immune checkpoint blockade therapy achieves significant combinatorial benefits. CONCLUSIONS: This study provides a novel mechanism by which GDE-circPRKD3 relies on STAT3 signaling to remodel immunosuppressive TME and offers a potential RNA immunotherapy strategy for GBM treatment.
引用
- Zhang X, Jiang M, Niu W, et al. CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling. Neuro Oncol. 2025. PMID: 39868921. doi:10.1093/neuonc/noaf019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。